Hepregen

BioTech/Drugs - Medford, MA, US

Hepregen Details

The mission of Hepregen Corporation is to transform safety assessment and drug development in order to significantly impact patients' lives. The company is focused on advancing and commercializing its microliver platform, HepatoPac, into the drug-development pipeline of pharmaceutical and biotechnology companies. We have utilized microtechnology tools adapted from the semiconductor industry to both optimize and miniaturize in multi-well formats an in vitro model of the human liver called HepatoPac, a micro-patterned co-culture (MPCC).Specifically, human hepatocytes are organized into colonies of prescribed, optimized dimensions using microfabrication tools and subsequently surrounded by supportive, non- parenchymal cells.Hepatocytes in HepatoPac retain their in vivo-like morphology, express liver genes, metabolize com- pounds using active Phase I and Phase II drug metabolism enzymes, secrete diverse liver‐specific products, and display functional bile canaliculi for up to 4 weeks in vitro Hepregen's technology offers the potential to be a more predictive platform for toxicity screening and for drug discovery. It combines sophisticated biological and engineering technologies to create an in vitro liver model which closely mimics many key functions and features of the in vivo human liver. HepatoPac fits into existing work-flows and is amenable to High Content Screening, allowing it to become an integral part of preclinical analysis for DMPK and Safety. In addition, HepatoPac can also be utilized for: efficacy assessment of drugs affecting the liver, biomarker identification, creation of diseased liver models, and utilization with stem cells. Currently, Hepregen is partnered with over 20 pharmaceutical companies using the HepatoPac technology, In 2008, Battelle Ventures spun out Hepregen Corporation from the Massachusetts Institute of Technology (MIT), and led the company's Series A financing.

Hepregen logo, Hepregen contact details
Website: hepregen.com
Employees: 20 - 49
HQ: 781-391-0205
Location: Medford, MA, US
Revenue: 20 - 50 Million
Liver DMPK In vitro testing Tox B2B BioTech/Drugs Commercial Physical Research Biotechnology
Hepregen Technologies
Email Providers

Outlook

Hosting

Google Cloud Hosting

View All Technologies Used At Hepregen

Contacting Hepregen: Connect with Executives and Employees

Get in Touch with Hepregen Executives and Employees

Connecting with Hepregen's Executives and Workforce

Accessing Contact Information for Hepregen Executives

Connecting with Hepregen: Reach Out to Their Team

Discover How to Contact Hepregen Executives and Staff

Looking to connect with Hepregen executives or employees?

Seeking to Get in Touch with Hepregen Executives or Staff?

Want to Reach Out to Hepregen Executives or Team Members?

In Search of Contact Details for Hepregen Professionals?

Connecting with Hepregen: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z